ARKB vs ARKG
ARK 21Shares Bitcoin ETF vs ARK Genomic Revolution ETF
ARKB$24.64
ARK 21Shares Bitcoin ETF
Spot Bitcoin ETF from ARK and 21Shares.
Expense: 0.21%Yield: 0.00%
ARKG$47.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
Quick take
- • ARKB has the lower expense ratio at 0.21% vs 0.75% for ARKG.
Side-by-side metrics
| Metric | ARKB | ARKG |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.21% | 0.75% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.00% |
AUM Assets under management — bigger funds are typically more liquid. | $2.36B | $2.21B |
YTD return | -14.67% | 66.55% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.00 | 2.11 |
P/E ratio | — | — |
Last price | $24.64 | $47.17 |
Inception | — | — |
Issuer | ARK | ARK |
ARKB top holdings
Holdings data unavailable for ARKB.
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
Sector breakdown · ARKG
Healthcare100.0%
About ARKB
ARKB (ARK 21Shares Bitcoin ETF) is Spot Bitcoin ETF from ARK and 21Shares. Managed by ARK, the fund carries $2.4B in assets under management, an expense ratio of 0.21%.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.